Since there is no abstract we provide the first sentence
Bollet and colleagues [1] provide useful data for clinicians and young patients with breast cancer. Although breast-conserving therapy has become the standard of care for early-stage breast cancer [2], caution and careful selection of patients for BCT is required because of LRR risk particularly in young patients [3].